Key Finding
A network meta-analysis of 182 RCTs found that biofeedback, spiritual interventions, and mindfulness-based interventions produced large, statistically significant reductions in depression symptoms in cancer patients, while yoga, mindfulness, Qigong/Tai Chi, physical relaxation, and music therapy were most effective for anxiety.
Dealing with depression and anxiety is one of the hardest parts of a cancer diagnosis. Many people want to explore gentle, non-medication approaches alongside their conventional treatment. A major new research review has looked at exactly this, examining whether mind-body therapies — practices that connect mental focus with physical experience — can genuinely help.
Researchers analysed 182 clinical trials involving nearly 17,000 cancer patients. They compared a wide range of mind-body therapies including yoga, mindfulness meditation, biofeedback, music therapy, Tai Chi, Qigong, physical relaxation techniques, and spiritual interventions, measuring how well each reduced depression and anxiety symptoms.
The results were encouraging. For depression, biofeedback, spiritual interventions, and mindfulness-based practices showed the strongest benefits. For anxiety, yoga came out on top, followed closely by mindfulness, physical relaxation, Qigong and Tai Chi, and music therapy. These weren't small effects — the researchers described them as "large," meaning real, meaningful improvements in how patients felt day to day.
So where does acupuncture fit in? While acupuncture was not one of the therapies directly compared in this study, it is widely recognised as a complementary mind-body practice that integrates physical treatment with a calming, focused therapeutic experience. Many cancer patients already use acupuncture alongside chemotherapy and other treatments to manage stress, improve sleep, and support emotional wellbeing. The growing body of evidence for mind-body approaches as a whole strengthens the case for including practices like acupuncture in a personalised cancer care plan.
If you are living with cancer and struggling with low mood or anxiety, these findings suggest that mind-body therapies are worth discussing with your oncology team. Always seek care from a qualified, licensed acupuncture practitioner with experience in oncology settings.
This systematic review and network meta-analysis (NMA) evaluated the comparative effectiveness of mind-body therapies (MBTs) for depression and anxiety in oncology populations. Searches across ten databases yielded 182 RCTs involving 16,835 participants. NMA enabled hierarchical ranking of interventions against usual care.
For depression symptom reduction, biofeedback (SMD = -1.18, p = 0.038), spiritual interventions (SMD = -0.98, p = 0.047), and mindfulness-based interventions (MBIs; SMD = -0.87, p < 0.001) demonstrated statistically significant large effects. For anxiety, yoga (SMD = -1.13, p < 0.001), MBIs (SMD = -1.02, p < 0.001), physical relaxation (SMD = -0.93, p < 0.001), Qigong/Tai Chi (SMD = -0.90, p = 0.004), and music therapy (SMD = -0.90, p < 0.001) showed significant large effects versus usual care.
Clinical takeaway: MBTs — including Qigong and Tai Chi, disciplines integral to TCM practice — demonstrate robust, evidence-supported efficacy for cancer-related psychological distress. Practitioners should consider integrating or recommending these modalities as adjuncts within oncology care pathways.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A Bayesian network meta-analysis protocol has been registered to systematically compare the efficacy and acceptability of non-invasive brain stimulation and acupuncture for depression across 14 databases, with results expected to provide evidence-based rankings of non-pharmacological treatment options.
📌 A meta-analysis of 66 RCTs found that acupuncture combined with SSRIs or SNRIs significantly reduced depression severity and increased remission rates by nearly 60% compared to antidepressant medication alone.
📌 Electroacupuncture significantly reduced depression scores (HAMD and SDS), improved stroke recovery and daily functioning, and raised serotonin levels and cerebral blood flow in 853 post-stroke depression patients across 11 randomized controlled trials.